Andere Sprachen Thermo Fisher Scientific, Inc.

Aktien

857209

US8835561023

TMO

Medizinische Ausrüstung

Markt geschlossen - Nyse Andere Börsenplätze 22:00:02 16.01.2026			% 5 Tage	Veränd. 1. Jan.
618,72 ^USD	-0,95 %		-0,02 %	+6,78 %

15.01.	Pharmasektor setzt verstärkt auf KI in der Hoffnung, Kosten und Entwicklungszeiten drastisch zu senken	RE
13.01.	Thermo Fisher gewinnt Aufträge, da Pharmaindustrie Produktion in die USA verlagert, sagt CEO	RE

Andere Sprachen

15.01.	Pharma sector doubles down on AI amid hopes of slashing costs, timelines
13.01.	Thermo Fisher wins contracts as pharma shifts production to US, CEO says
13.01.	Thermo Fisher Scientific : J.P. Morgan Healthcare Conference
13.01.	Thermo Fisher Scientific announces strategic collaboration with Nvidia
12.01.	Health Care Down on Health-Insurance Concerns -- Health Care Roundup
12.01.	Thermo Fisher Scientific Announces Strategic Collaboration With NVIDIA Leveraging AI to Advance Scientific Instrumentation and Accelerate Laboratory Performance
12.01.	Thermo Fisher Scientific Announces Strategic Collaboration with NVIDIA Leveraging AI to Advance Scientific Instrumentation and Accelerate Laboratory Performance
12.01.	Thermo Fisher Scientific Inc. Promotes Marc N. Casper as Chief Executive Officer, Effective March 1, 2026
12.01.	Henry Schein, Inc. Announces Management Changes
12.01.	Henry Schein, Inc. Appoints Frederick M. Lowery as Chief Executive Officer, Effective March 2, 2026
12.01.	Nvidia, Lilly Launching AI Lab for Drug Discovery Projects
12.01.	Nvidia, Eli Lilly to Launch AI-Powered Co-Innovation Lab -- Update
12.01.	Nvidia, Eli Lilly to Launch AI-Powered Co-Innovation Lab
12.01.	Henry Schein Names Frederick Lowery Chief Executive Officer
12.01.	TetraScience Announces Collaboration with Thermo Fisher Scientific Inc. to Accelerate Scientific Data and AI Enablement Across the Laboratory
12.01.	Henry Schein Names Frederick Lowery Chief Executive
12.01.	Thermo Fisher Chief Operating Officer Michel Lagarde Leaving Company
12.01.	Henry Schein, Inc. Announces the Appointment of Frederick M. Lowery to the Board of Directors, Effective March 2, 2026
06.01.	Thermo Fisher Scientific to Present at the J.P. Morgan 2026 Healthcare Conference
06.01.	Thermo Fisher Scientific Inc. Launches CorEvitas Obesity Registry to Advance Real-World Evidence in Treatment Outcomes
29.12.	Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, January 29, 2026
26.12.	Thermo Fisher Scientific to hold earnings conference call on Thursday, January 29, 2026
26.12.	Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, January 29, 2026
18.12.	Thermo Fisher Scientific Launches PPD CorEvitas Alzheimer's Disease Registry to Advance Real-World Evidence in Neurodegenerative Care
15.12.	OlivePoint Capital Acquires 3900 Paramount Parkway in Raleigh–Durham, Expanding Its High-Conviction Office Special Situations Strategy

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen MarketScreener Artikel MarketScreener Analysen Trading-Ideen

Filter

Schlagzeilen

Thermo Fisher Scientific: Akquisitionsstrategie überzeugt (noch) nicht

Am 23. Juli 2025 um 14:41 Uhr